SSKN - メラ・サイエンス (Strata Skin Sciences Inc.)

SSKNのニュース

   The Daily Biotech Pulse: Translate Bio's Cystic Fibrosis Study Disappoints, Adverum Nominates Directors, Gain Therapeutics To Debut On Nasdaq  2021/03/18 12:16:32 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 17) AngioDynamics, Inc. (NASDAQ: ANGO ) Anixa Biosciences, Inc. (NASDAQ: ANIX ) BioAtla, Inc. (NASDAQ: BCAB ) Harvard Bioscience, Inc. (NASDAQ: HBIO ) IDEAYA Biosciences, Inc. (NASDAQ: IDYA ) Immatics N.V. (NASDAQ: IMTX ) ( announced positive Phase 1 readout for a trio of candidates in solid tumors) NGM Biopharmaceuticals, Inc. (NASDAQ: NGM ) NuVasive, Inc. (NASDAQ: NUVA ) Omnicell, Inc. (NASDAQ: OMCL ) Oncternal Therapeutics, Inc. (NASDAQ: ONCT ) Organogenesis Holdings Inc. (NASDAQ: ORGO ) PLx Pharma Inc. (NASDAQ: PLXP ) Sierra Oncology, Inc. (NASDAQ: SRRA ) Silverback Therapeutics, Inc. (NASDAQ: SBTX ) STRATA Skin Sciences, Inc. (NASDAQ: SSKN ) Urovant Sciences Ltd. (NASDAQ: UROV ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows March 17) Foghorn Therapeutics Inc. (NASDAQ: FHTX ) Galapagos NV (NASDAQ: GLPG ) Galecto, Inc. (NASDAQ: GLTO ) Stocks In Focus Translate Bio mRNA Product Candidate For Cystic Fibrosis Fails To Improve Lung Function In Phase 1/2 Study Translate Bio (NASDAQ: TBIO ) announced a second interim analysis from the Phase 1/2 study of MRT5005 in patients with cystic fibrosis, showing that repeat dosing was generally safe and well tolerated, with no serious adverse events.
   Thinking about buying stock in Communications Systems, TherapeuticsMD, STRATA Skin Sciences, Inovio Pharmaceuticals, or Inseego Corp?  2021/03/02 15:45:00 PR Newswire
NEW YORK, March 2, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for JCS, TXMD, SSKN, INO, and INSG. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   34 Stocks Moving in Tuesday's Pre-Market Session  2021/03/02 07:01:00 Benzinga
Gainers Great Elm Group, Inc. (NASDAQ: GEG) shares rose 143.4% to $8.39 in pre-market trading after climbing around 15% on Monday. STRATA Skin Sciences, …
   STRATA Skin Sciences to Participate in the H.C. Wainwright BioConnect Virtual Conference  2021/01/06 16:15:00 GlobeNewswire
HORSHAM, Pa., Jan. 06, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in…
   Strata Skin Sciences: Q3 Earnings Insights  2020/11/10 08:31:00 Benzinga
Shares of Strata Skin Sciences (NASDAQ:SSKN) remained unaffected after the company reported Q3 results. Quarterly Results Earnings per share fell …
   The Daily Biotech Pulse: Translate Bio's Cystic Fibrosis Study Disappoints, Adverum Nominates Directors, Gain Therapeutics To Debut On Nasdaq  2021/03/18 12:16:32 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 17) AngioDynamics, Inc. (NASDAQ: ANGO ) Anixa Biosciences, Inc. (NASDAQ: ANIX ) BioAtla, Inc. (NASDAQ: BCAB ) Harvard Bioscience, Inc. (NASDAQ: HBIO ) IDEAYA Biosciences, Inc. (NASDAQ: IDYA ) Immatics N.V. (NASDAQ: IMTX ) ( announced positive Phase 1 readout for a trio of candidates in solid tumors) NGM Biopharmaceuticals, Inc. (NASDAQ: NGM ) NuVasive, Inc. (NASDAQ: NUVA ) Omnicell, Inc. (NASDAQ: OMCL ) Oncternal Therapeutics, Inc. (NASDAQ: ONCT ) Organogenesis Holdings Inc. (NASDAQ: ORGO ) PLx Pharma Inc. (NASDAQ: PLXP ) Sierra Oncology, Inc. (NASDAQ: SRRA ) Silverback Therapeutics, Inc. (NASDAQ: SBTX ) STRATA Skin Sciences, Inc. (NASDAQ: SSKN ) Urovant Sciences Ltd. (NASDAQ: UROV ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows March 17) Foghorn Therapeutics Inc. (NASDAQ: FHTX ) Galapagos NV (NASDAQ: GLPG ) Galecto, Inc. (NASDAQ: GLTO ) Stocks In Focus Translate Bio mRNA Product Candidate For Cystic Fibrosis Fails To Improve Lung Function In Phase 1/2 Study Translate Bio (NASDAQ: TBIO ) announced a second interim analysis from the Phase 1/2 study of MRT5005 in patients with cystic fibrosis, showing that repeat dosing was generally safe and well tolerated, with no serious adverse events.
   Thinking about buying stock in Communications Systems, TherapeuticsMD, STRATA Skin Sciences, Inovio Pharmaceuticals, or Inseego Corp?  2021/03/02 15:45:00 PR Newswire
NEW YORK, March 2, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for JCS, TXMD, SSKN, INO, and INSG. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   34 Stocks Moving in Tuesday's Pre-Market Session  2021/03/02 07:01:00 Benzinga
Gainers Great Elm Group, Inc. (NASDAQ: GEG) shares rose 143.4% to $8.39 in pre-market trading after climbing around 15% on Monday. STRATA Skin Sciences, …
   STRATA Skin Sciences to Participate in the H.C. Wainwright BioConnect Virtual Conference  2021/01/06 16:15:00 GlobeNewswire
HORSHAM, Pa., Jan. 06, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in…
   Strata Skin Sciences: Q3 Earnings Insights  2020/11/10 08:31:00 Benzinga
Shares of Strata Skin Sciences (NASDAQ:SSKN) remained unaffected after the company reported Q3 results. Quarterly Results Earnings per share fell …
   The Daily Biotech Pulse: Translate Bio's Cystic Fibrosis Study Disappoints, Adverum Nominates Directors, Gain Therapeutics To Debut On Nasdaq  2021/03/18 12:16:32 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 17) AngioDynamics, Inc. (NASDAQ: ANGO ) Anixa Biosciences, Inc. (NASDAQ: ANIX ) BioAtla, Inc. (NASDAQ: BCAB ) Harvard Bioscience, Inc. (NASDAQ: HBIO ) IDEAYA Biosciences, Inc. (NASDAQ: IDYA ) Immatics N.V. (NASDAQ: IMTX ) ( announced positive Phase 1 readout for a trio of candidates in solid tumors) NGM Biopharmaceuticals, Inc. (NASDAQ: NGM ) NuVasive, Inc. (NASDAQ: NUVA ) Omnicell, Inc. (NASDAQ: OMCL ) Oncternal Therapeutics, Inc. (NASDAQ: ONCT ) Organogenesis Holdings Inc. (NASDAQ: ORGO ) PLx Pharma Inc. (NASDAQ: PLXP ) Sierra Oncology, Inc. (NASDAQ: SRRA ) Silverback Therapeutics, Inc. (NASDAQ: SBTX ) STRATA Skin Sciences, Inc. (NASDAQ: SSKN ) Urovant Sciences Ltd. (NASDAQ: UROV ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows March 17) Foghorn Therapeutics Inc. (NASDAQ: FHTX ) Galapagos NV (NASDAQ: GLPG ) Galecto, Inc. (NASDAQ: GLTO ) Stocks In Focus Translate Bio mRNA Product Candidate For Cystic Fibrosis Fails To Improve Lung Function In Phase 1/2 Study Translate Bio (NASDAQ: TBIO ) announced a second interim analysis from the Phase 1/2 study of MRT5005 in patients with cystic fibrosis, showing that repeat dosing was generally safe and well tolerated, with no serious adverse events.
   Thinking about buying stock in Communications Systems, TherapeuticsMD, STRATA Skin Sciences, Inovio Pharmaceuticals, or Inseego Corp?  2021/03/02 15:45:00 PR Newswire
NEW YORK, March 2, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for JCS, TXMD, SSKN, INO, and INSG. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   34 Stocks Moving in Tuesday's Pre-Market Session  2021/03/02 07:01:00 Benzinga
Gainers Great Elm Group, Inc. (NASDAQ: GEG) shares rose 143.4% to $8.39 in pre-market trading after climbing around 15% on Monday. STRATA Skin Sciences, …
   STRATA Skin Sciences to Participate in the H.C. Wainwright BioConnect Virtual Conference  2021/01/06 16:15:00 GlobeNewswire
HORSHAM, Pa., Jan. 06, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in…
   Strata Skin Sciences: Q3 Earnings Insights  2020/11/10 08:31:00 Benzinga
Shares of Strata Skin Sciences (NASDAQ:SSKN) remained unaffected after the company reported Q3 results. Quarterly Results Earnings per share fell …

calendar